Acceptabilité du vaccin-Sars CoV-2 chez les femmes enceintes, une enquête transversale par questionnaire

OBJECTIVE: SARS-CoV-2 is more likely to cause severe cases in pregnant women. They were part of the priority groups since April 2021 to benefit from SARS-CoV-2 vaccination before its extent to general population. This contribution aims to evaluate, in the postpartum period, the achievement of COVID-...

Descripción completa

Detalles Bibliográficos
Autores principales: Huré, M., Peyronnet, V., Sibiude, J., Cazenave, M.G., Anselem, O., Luton, D., Vauloup-Fellous, C., Deruelle, P., Cordier, A.G., Benachi, A., Mandelbrot, L., Couffignal, C., Pauphilet, V., Vivanti, A.J., Picone, O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2022
Materias:
Article Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335352/
https://www.ncbi.nlm.nih.gov/pubmed/35914734
http://dx.doi.org/10.1016/j.gofs.2022.07.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335352/
https://www.ncbi.nlm.nih.gov/pubmed/35914734
http://dx.doi.org/10.1016/j.gofs.2022.07.004

Ejemplares similares